India is taking a major step towards pharmaceutical innovation by launching a ₹5,000 crore Research & Development (R&D) fund to boost drug discovery and medical research. The initiative aims to position India as a global leader in pharmaceuticals by encouraging research in novel drug formulations, biologics, and cutting-edge healthcare technologies.
The fund will provide financial support to pharmaceutical companies, startups, and research institutions, fostering innovation in critical areas such as oncology, rare diseases, and precision medicine. This move aligns with the government's vision of strengthening the "Make in India" and "Atmanirbhar Bharat" initiatives, reducing dependency on imports and enhancing self-sufficiency in life-saving drugs.
With India's pharma sector projected to reach $130 billion by 2030, this investment in R&D is expected to drive groundbreaking advancements, attract global collaborations, and create new job opportunities. Experts believe that with increased funding, India can bridge the gap between generic drug production and high-end pharmaceutical innovation, further solidifying its position as the "Pharmacy of the World."
This strategic push for innovation marks a transformative era for India's pharmaceutical and healthcare ecosystem.
#PharmaInnovation #MakeInIndia #AtmanirbharBharat #HealthcareResearch #BiotechIndia #MedTech #PharmaR&D #DrugDiscovery #HealthcareInnovation #Dseidehealthcarenetwork
Source: IndiaMed Today
The fund will provide financial support to pharmaceutical companies, startups, and research institutions, fostering innovation in critical areas such as oncology, rare diseases, and precision medicine. This move aligns with the government's vision of strengthening the "Make in India" and "Atmanirbhar Bharat" initiatives, reducing dependency on imports and enhancing self-sufficiency in life-saving drugs.
With India's pharma sector projected to reach $130 billion by 2030, this investment in R&D is expected to drive groundbreaking advancements, attract global collaborations, and create new job opportunities. Experts believe that with increased funding, India can bridge the gap between generic drug production and high-end pharmaceutical innovation, further solidifying its position as the "Pharmacy of the World."
This strategic push for innovation marks a transformative era for India's pharmaceutical and healthcare ecosystem.
#PharmaInnovation #MakeInIndia #AtmanirbharBharat #HealthcareResearch #BiotechIndia #MedTech #PharmaR&D #DrugDiscovery #HealthcareInnovation #Dseidehealthcarenetwork
Source: IndiaMed Today
India is taking a major step towards pharmaceutical innovation by launching a ₹5,000 crore Research & Development (R&D) fund to boost drug discovery and medical research. The initiative aims to position India as a global leader in pharmaceuticals by encouraging research in novel drug formulations, biologics, and cutting-edge healthcare technologies.
The fund will provide financial support to pharmaceutical companies, startups, and research institutions, fostering innovation in critical areas such as oncology, rare diseases, and precision medicine. This move aligns with the government's vision of strengthening the "Make in India" and "Atmanirbhar Bharat" initiatives, reducing dependency on imports and enhancing self-sufficiency in life-saving drugs.
With India's pharma sector projected to reach $130 billion by 2030, this investment in R&D is expected to drive groundbreaking advancements, attract global collaborations, and create new job opportunities. Experts believe that with increased funding, India can bridge the gap between generic drug production and high-end pharmaceutical innovation, further solidifying its position as the "Pharmacy of the World."
This strategic push for innovation marks a transformative era for India's pharmaceutical and healthcare ecosystem.
#PharmaInnovation #MakeInIndia #AtmanirbharBharat #HealthcareResearch #BiotechIndia #MedTech #PharmaR&D #DrugDiscovery #HealthcareInnovation #Dseidehealthcarenetwork
Source: IndiaMed Today
